Enigma news, latest stories & analysis
Find today's trending Enigma news & headlines
Allakos Inc. down 80% after announcing topline phase III results from its Enigma II clinical study
- The researchers did Enigma II study in 24 weeks of randomized placebo-controlled research of lirentelimab.
- Both the Kryptos and Enigma studies met all their co-primary endpoints.
- Safety data were also generally consistent.
December 22, 2021
Top 10 Cryptocurrencies 2019
September 15, 2019